Martyn Caplin

28.4k total citations · 7 hit papers
293 papers, 16.0k citations indexed

About

Martyn Caplin is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Martyn Caplin has authored 293 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Epidemiology, 214 papers in Oncology and 178 papers in Neurology. Recurrent topics in Martyn Caplin's work include Neuroendocrine Tumor Research Advances (261 papers), Lung Cancer Research Studies (178 papers) and Neuroblastoma Research and Treatments (174 papers). Martyn Caplin is often cited by papers focused on Neuroendocrine Tumor Research Advances (261 papers), Lung Cancer Research Studies (178 papers) and Neuroblastoma Research and Treatments (174 papers). Martyn Caplin collaborates with scholars based in United Kingdom, Germany and United States. Martyn Caplin's co-authors include Christos Toumpanakis, Guido Rindi, Philippe Ruszniewski, Wouter W. de Herder, Robert T. Jensen, Jamshed Bomanji, Bertram Wiedenmann, Ola Nilsson, Jaume Capdevila and Joseph Davar and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Martyn Caplin

279 papers receiving 15.7k citations

Hit Papers

Lanreotide in Metastatic ... 2006 2026 2012 2019 2014 2008 2006 2016 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
    2014 1.3k citations Martyn Caplin, Marianne Pavel et al. profile →
  2. Gastroenteropancreatic neuroendocrine tumours
    2008 1.2k citations Robert T. Jensen, Wouter W. de Herder et al. profile →
  3. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
    2006 1.2k citations Martyn Caplin, Wouter W. de Herder et al. profile →
  4. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
    2016 911 citations Massimo Falconi, Barbro Eriksson et al. Neuroendocrinology profile →
  5. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
    2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
  6. Recommendations for management of patients with neuroendocrine liver metastases
    2014 349 citations Andrea Frilling, Martyn Caplin et al. profile →
  7. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
    2018 272 citations Matthew H. Kulke, Martyn Caplin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Martyn Caplin 13.7k 12.4k 9.5k 1.6k 910 293 16.0k
Larry K. Kvols 10.2k 0.7× 9.2k 0.7× 7.3k 0.8× 1.5k 0.9× 1.0k 1.1× 225 13.8k
Dermot O’Toole 6.3k 0.5× 6.8k 0.5× 3.6k 0.4× 3.2k 2.0× 285 0.3× 206 10.1k
Manal M. Hassan 5.8k 0.4× 5.9k 0.5× 2.6k 0.3× 1.6k 1.0× 758 0.8× 159 10.3k
Joseph Rubin 4.3k 0.3× 5.6k 0.4× 3.2k 0.3× 1.8k 1.1× 648 0.7× 98 8.6k
Þorvarður R. Hálfdánarson 3.2k 0.2× 4.3k 0.3× 1.8k 0.2× 1.1k 0.7× 139 0.2× 267 6.4k
Lowell Anthony 3.8k 0.3× 3.7k 0.3× 2.7k 0.3× 347 0.2× 303 0.3× 175 5.0k
Halfdan Sørbye 3.4k 0.2× 6.5k 0.5× 2.1k 0.2× 1.5k 1.0× 73 0.1× 160 8.1k
Eugene A. Woltering 2.8k 0.2× 2.4k 0.2× 2.0k 0.2× 754 0.5× 408 0.4× 162 4.5k
C G Moertel 2.1k 0.2× 5.6k 0.5× 1.4k 0.1× 2.4k 1.5× 193 0.2× 77 7.6k
Daniel M. Halperin 3.4k 0.2× 3.1k 0.3× 2.1k 0.2× 305 0.2× 134 0.1× 102 4.2k

Countries citing papers authored by Martyn Caplin

Since Specialization
Citations

This map shows the geographic impact of Martyn Caplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martyn Caplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martyn Caplin more than expected).

Fields of papers citing papers by Martyn Caplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martyn Caplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martyn Caplin. The network helps show where Martyn Caplin may publish in the future.

Co-authorship network of co-authors of Martyn Caplin

This figure shows the co-authorship network connecting the top 25 collaborators of Martyn Caplin. A scholar is included among the top collaborators of Martyn Caplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martyn Caplin. Martyn Caplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glover, Thomas, Aimee R. Hayes, Dalvinder Mandair, et al.. (2024). Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence. Journal of Neuroendocrinology. 37(1). e13465–e13465.
2.
Khan, Mohid S., Kathryn Cook, Martin O. Weickert, et al.. (2024). PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK. Supportive Care in Cancer. 32(3). 199–199. 2 indexed citations
3.
Kmiotek, Elizabeth, Aditya Borakati, Olagunju Ogunbiyi, et al.. (2023). Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review. Current Oncology. 30(10). 9192–9204.
4.
Gnanasegaran, Gopinath, Ann‐Marie Quigley, Dalvinder Mandair, et al.. (2022). Single centre retrospective review of outcome of 177 Lu‐DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors. Journal of Neuroendocrinology. 34(11). e13210–e13210. 5 indexed citations
5.
Cives, Mauro, Jorge Hernando, Ángela Lamarca, et al.. (2022). The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients. Journal of Neuroendocrinology. 34(10). e13196–e13196. 2 indexed citations
6.
Navalkissoor, Shaunak, Christos Toumpanakis, Martyn Caplin, & Gopinath Gnanasegaran. (2022). Treatment of neuroendocrine tumours with 177 Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management. Journal of Neuroendocrinology. 34(4). e13088–e13088. 4 indexed citations
7.
Borbath, Ivan, Ulrich‐Frank Pape, Pierre H. Deprez, et al.. (2022). ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. Journal of Neuroendocrinology. 34(3). e13105–e13105. 13 indexed citations
8.
Wong, Yien Ning Sophia, Ayse U. Akarca, Pawan Dhami, et al.. (2022). Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors. Clinical Cancer Research. 28(12). 2657–2668. 7 indexed citations
9.
Luong, Tu Vinh, et al.. (2021). Middle ear neuroendocrine tumours: Insight into their pathogenesis, diagnosis and management. Journal of Neuroendocrinology. 33(9). e13031–e13031. 3 indexed citations
10.
Sørbye, Halfdan, Éric Baudin, Ivan Borbath, et al.. (2018). Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). Neuroendocrinology. 108(1). 54–62. 65 indexed citations
11.
García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294. 82 indexed citations
12.
Pavel, Marianne, Juan W. Valle, Barbro Eriksson, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 105(3). 266–280. 110 indexed citations
13.
Kaltsas, Gregory, Martyn Caplin, Philippa Davies, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 105(3). 245–254. 99 indexed citations
14.
García‐Carbonero, Rocio, Halfdan Sørbye, Éric Baudin, et al.. (2016). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology. 103(2). 186–194. 403 indexed citations breakdown →
15.
Khan, Mohid S., Amy A. Kirkwood, Theodora Tsigani, et al.. (2015). Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms. Clinical Cancer Research. 22(1). 79–85. 66 indexed citations
16.
Khan, Mohid S., Theodora Tsigani, Mohammed Rashid, et al.. (2011). Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. Clinical Cancer Research. 17(2). 337–345. 90 indexed citations
17.
Khan, Theodora Tsigani, Jorge García-Hernández, Martyn Caplin, & Tim Meyer. (2011). Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). UCL Discovery (University College London). 1 indexed citations
18.
Ahmed, Alia, G. Turner, Barbara King, et al.. (2009). Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocrine Related Cancer. 16(3). 885–894. 215 indexed citations
19.
Toumpanakis, Christos & Martyn Caplin. (2008). Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors. The American Journal of Gastroenterology. 103(3). 729–732. 41 indexed citations
20.
Aviv, Ricardo, et al.. (2002). Use of Stents in the Palliative Treatment of Malignant Gastric Outlet and Duodenal Obstruction. Clinical Radiology. 57(7). 587–592. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry K. Kvols Breakdown of academic impact, for papers by Dermot O’Toole Breakdown of academic impact, for papers by Manal M. Hassan Breakdown of academic impact, for papers by Joseph Rubin Breakdown of academic impact, for papers by Þorvarður R. Hálfdánarson Breakdown of academic impact, for papers by Lowell Anthony Breakdown of academic impact, for papers by Halfdan Sørbye Breakdown of academic impact, for papers by Eugene A. Woltering Breakdown of academic impact, for papers by C G Moertel Breakdown of academic impact, for papers by Daniel M. Halperin
Rankless by CCL
2026